| WO2017060855 | Arylcyclohexyl pyrazoles as NRF2 regulators | GlaxoSmithKline Astex Therapeutics |
| WO2016/202253 | NRF2 regulators | GlaxoSmithKline Astex Therapeutics, GlaxoSmithKline (China), R&D |
| WO2014/197818 | Small-molecule activators of NRF2 pathway | General Hospital, Regents of the University of California |
| WO2013/067036 | Direct inhibitors of KEAP1–NRF2 interaction as antioxidant inflammation modulators | Rutgers, The State University of New Jersey, Broad Institute |
| WO2011/156889 | Novel modulators of NRF2 and uses thereof | TRT Pharma Gerald Batist, Jian Hui Wu |
| JP2011/0167537 | KEAP1 protein-binding compound, crystal of complex between the same and KEAP1 protein, and method for producing the same | Toray Industries |
| WO2017124835 | 1-sulfonamido-4-aryloxy compound, and preparation method and medicinal application thereof | China Pharmaceutical University |
| WO2015/092713 | NRF2 regulators | GlaxoSmithKline Astex Therapeutics Limited |
| WO2011156889A1 | Novel regulators of NRF2 and uses thereof | TRT Pharma Gerald Batist, Jian Hui Wu |
| WO2016/202253 | NRF2 regulators | GlaxoSmithKline Astex Therapeutics, GlaxoSmithKline (China), R&D CO., LTD |